NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

TSX · Drug Manufacturers - Specialty & Generic · CAD

Avant Brands Inc. (AVNT.TO) Stock Analysis

Avant Brands Inc. (AVNT.TO) is a Drug Manufacturers - Specialty & Generic stock listed on TSX and quoted in Canadian Dollar.

Last Updated: October 21, 2026

AVNT.TO

CA$0.46

−CA$0.08 (−14.81%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AVNT.TO with… →

AVNT.TO Key Statistics

As of Oct 21, 2026
Trading
Open
CA$0.53
Previous Close
CA$0.54
Day's Range
0.46–0.53
52-Week Range
0.45–1.07
Volume
1.97K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.32
Valuation
Market Cap
CA$6.93M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.22
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.70
Financials (FY)
Revenue (FY)
CA$35.90M+0.26%
Net Income (FY)
−CA$9.88M
Profit marginThe share of revenue left as profit after all costs and taxes.
−30.82%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
15.07M
1-Year Return
−25.81%
Dividend and dates
Avg Volume
8.66K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, AVNT.TO closed at CA$0.46, −25.81% over 1 year.

Avant Brands Inc. (AVNT.TO) has a market capitalization of CA$6.93M.

In fiscal 2025, AVNT.TO reported revenue of CA$35.90M.

AVNT.TO Stock Return by Calendar Year

Avant Brands Inc. (AVNT.TO) return since Jun 2018: what CA$10,000 became

1 year
CA$10,000 CA$7,419
−25.81%
5 years
CA$10,000 CA$352
−96.48%
Since Jun 2018
CA$10,000 CA$110
−98.90%

If you had invested CA$10,000 in Avant Brands Inc. (AVNT.TO) at the close on June 22, 2018, the earliest close on record here, it would have been worth CA$110 at the close on October 21, 2026: −98.90% in total, −41.83% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−48.89%
2025+73.08%
2024−87.62%
2023−15.15%
2022−52.86%
2021+233.33%
2020−48.78%
2019−58.16%
2018 (partial year)−65.00%

As of October 21, 2026.

AVNT.TO Revenue and Earnings by Fiscal Year

FY ends November
Fiscal yearRevenueNet incomeNet margin
2025CA$35.90M−CA$9.88M−27.5%
2024CA$35.80M−CA$22.55M−63.0%
2023CA$26.34M−CA$5.07M−19.2%
2022CA$20.15M−CA$7.54M−37.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025CA$35.90MCA$4.57M−CA$6.16M−CA$9.88M−27.5%
2024CA$35.80M−CA$1.68M−CA$14.14M−CA$22.55M−63.0%
2023CA$26.34MCA$12.43M−CA$1.45M−CA$5.07M−19.2%
2022CA$20.15MCA$3.91M−CA$8.54M−CA$7.54M−37.4%

Annual figures as reported, in the company's reporting currency. As of November 30, 2025.

AVNT.TO Valuation vs Drug Manufacturers - Specialty & Generic Median

Median of 97 stocks
MetricAVNT.TODrug Manufacturers - Specialty & Generic medianvs median
P/S ratio0.222.100.1x the median
Profit margin−30.82%−8.14%22.7 pts below

Medians across 97 Drug Manufacturers - Specialty & Generic stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

The market values Avant Brands Inc. (AVNT.TO) at CA$6.93M. It is classified in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector. The company reports 180 employees.

The most recent close on file for AVNT.TO is CA$0.46, dated October 21, 2026. That is −CA$0.08 (−14.81%) against the previous close. Over the past 52 weeks the price has ranged from CA$0.45 to CA$1.07. The latest close sits 2.22% above that 52-week low.

Financial Health

In fiscal 2025, Avant Brands Inc. reported revenue of CA$35.90M. That is +0.26% against the prior fiscal year, when revenue was CA$35.80M. The same year closed with a net loss of CA$9.88M. The reported profit margin is −30.82%. That is 22.7 percentage points below the Drug Manufacturers - Specialty & Generic median of −8.14%. Trailing earnings per share are −0.7.

Across the 4 fiscal years on file, revenue moves from CA$20.15M in 2022 to CA$35.90M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 0.22. On price-to-sales that is 0.1 times the Drug Manufacturers - Specialty & Generic median of 2.1. 97 Drug Manufacturers - Specialty & Generic companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −25.81%. Measured over 5 years, that is −48.78% a year compounded. The reported beta is 1.32. Daily returns over the trailing 8 years annualize to a volatility of 98.33%.

Growth & Income

No dividend is on file for AVNT.TO.

The strongest complete calendar year on file is 2021 at +233.33%; the weakest is 2024 at −87.62%. Of the 7 complete calendar years on file, 2 finished higher. 2026 is still running; the total return is −48.89% year to date.

Peer Comparison

Avant Brands Inc. (AVNT.TO) operates in the Drug Manufacturers - Specialty & Generic industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Avant Brands Inc. AVNT.TO CA$6.93M —
Takeda Pharmaceutical Company Limited TAK $63.67B —
Teva Pharmaceutical Industries Limited TEVA $47.37B 67.7
Haleon plc HLN $44.06B 20.5

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

The Drug Manufacturers - Specialty & Generic industry average P/E ratio is 20.3x. Avant Brands Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Drug Manufacturers - Specialty & Generic Stocks

TAK

Takeda Pharmaceutical Company Limited

$63.67B

 TEVA

Teva Pharmaceutical Industries Limited

$47.37B

 HLN

Haleon plc

$44.06B

 ZTS

Zoetis Inc.

$32.90B

 UTHR

United Therapeutics Corporation

$24.17B

 VTRS

Viatris Inc.

$21.19B
View all Drug Manufacturers - Specialty & Generic stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Avant Brands Inc.

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada. The company offers recreational cannabis products under the BLK MKT, Tenzo, Cognoscente, Treehugger, Pristine, and Flowr brands. It also provides medical cannabis products under the GreenTec brand. The company distributes cannabis through medical and recreational sales channels, as well as an e-commerce website. It also exports its products through the wholesale channel. The company was formerly known as GTEC Holdings Ltd. and changed its name to Avant Brands Inc. in July 2021. Avant Brands Inc. is headquartered in Kelowna, Canada.

Visit website →